Table 3 Eye disorders among adverse drug reactions.
Safety profile | HA 0.15% | CsA 0.05% + CMC 0.5% | HA 0.15% + CsA 0.05% |
|---|---|---|---|
Subjects with eye disorder (%) | 3 (2.46) | 12 (9.92) | 12 (9.92) |
Eye pain | 1 (0.82) | 10 (8.26) | 4 (3.31) |
Eye irritation | 0 | 1 (0.83) | 2 (1.65) |
Ocular hyperemia | 0 | 2 (1.65) | 0 |
Abnormal sensation in eye | 0 | 0 | 1 (0.83) |
Asthenopia | 0 | 0 | 1 (0.83) |
Blepharitis | 0 | 0 | 1 (0.83) |
Conjunctival hemorrhage | 0 | 1 (0.83) | 0 |
Conjunctivitis allergic | 1 (0.82) | 0 | 0 |
Eye discharge | 0 | 0 | 1 (0.83) |
Eye pruritus | 0 | 0 | 1 (0.83) |
Foreign body sensation in eyes | 1 (0.82) | 0 | 0 |
Ocular discomfort | 0 | 0 | 1 (0.83) |
Visual impairment | 0 | 0 | 1 (0.83) |
